Literature DB >> 12353506

Folic acid and prevention of spina bifida and anencephaly. 10 years after the U.S. Public Health Service recommendation.

J David Erickson.   

Abstract

In September 1992, the U.S. Public Health Service (USPHS) recommended that all women capable of becoming pregnant should consume 400 microg of folic acid/day on an ongoing basis to reduce their risk for having a pregnancy affected by spina bifida and anencephaly (i.e., neural tube defects [NTDs]). The recommendation was preceded a year earlier by a CDC recommendation for women at high risk (i.e., those women who have had an earlier pregnancy affected by an NTD). The 1991 CDC recommendation stated that women at high risk should plan subsequent pregnancies and consume 4,000 microg/day of folic acid from the time they begin trying to become pregnant through the first trimester of pregnancy to reduce their risk. The 1992 USPHS recommendation specified that women at high risk should follow the general population recommendation for consumption of 400 microg/day when not trying to become pregnant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353506

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  10 in total

Review 1.  Current perspectives on the genetic causes of neural tube defects.

Authors:  Patrizia De Marco; Elisa Merello; Samantha Mascelli; Valeria Capra
Journal:  Neurogenetics       Date:  2006-08-29       Impact factor: 2.660

2.  Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification.

Authors:  Tanya G K Bentley; Walter C Willett; Milton C Weinstein; Karen M Kuntz
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

3.  Folic acid throughout pregnancy: too much?

Authors:  Rose Schrott; Susan K Murphy
Journal:  Am J Clin Nutr       Date:  2018-04-01       Impact factor: 7.045

Review 4.  Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role.

Authors:  Krista S Crider; Thomas P Yang; Robert J Berry; Lynn B Bailey
Journal:  Adv Nutr       Date:  2012-01-05       Impact factor: 8.701

5.  Parity and the use of folic acid supplementation during pregnancy.

Authors:  Sarah Sharman Moser; Maayan Rabinovitch; Ran Rotem; Gideon Koren; Varda Shalev; Gabriel Chodick
Journal:  BMJ Nutr Prev Health       Date:  2019-05-19

6.  MTHFR methylation moderates the impact of smoking on DNA methylation at AHRR for African American young adults.

Authors:  Steven R H Beach; Man Kit Lei; Mei Ling Ong; Gene H Brody; Meeshanthini V Dogan; Robert A Philibert
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-04-24       Impact factor: 3.568

7.  A cost-effectiveness analysis of folic acid fortification policy in the United States.

Authors:  Tanya Gk Bentley; Milton C Weinstein; Walter C Willett; Karen M Kuntz
Journal:  Public Health Nutr       Date:  2008-07-01       Impact factor: 4.022

Review 8.  Epidemiology, prenatal management, and prevention of neural tube defects.

Authors:  Mustafa A Salih; Waleed R Murshid; Mohammed Z Seidahmed
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

Review 9.  Folate deficiency as predisposing factor for childhood leukaemia: a review of the literature.

Authors:  Catia Daniela Cantarella; Denise Ragusa; Marco Giammanco; Sabrina Tosi
Journal:  Genes Nutr       Date:  2017-06-02       Impact factor: 5.523

10.  The methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism is associated with breast cancer subtype susceptibility in southwestern China.

Authors:  Zhen Li; Ji Zhang; Wei Zou; Qi Xu; Siyuan Li; Jie Wu; Li Zhu; Yunjiao Zhang; Lei Xu; Ying Zhang; Qingsong Luo; Jianyun Nie; Xingxu Li; Tianning Zou; Ceshi Chen
Journal:  PLoS One       Date:  2021-07-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.